NAOV NanoVibronix, Inc. Stock Quote

NAOV [NASD]

Index	-	P/E	-	EPS (ttm)	-0.37	Insider Own	12.15%	Shs Outstand	24.78M	Perf Week	-11.39%
Market Cap	52.35M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	21.18M	Perf Month	-28.57%
Income	-7.10M	PEG	-	EPS next Q	-	Inst Own	6.60%	Short Float	8.46%	Perf Quarter	136.01%
Sales	0.70M	P/S	74.79	EPS this Y	69.50%	Inst Trans	-4.08%	Short Ratio	0.08	Perf Half Y	82.61%
Book/sh	0.17	P/B	12.35	EPS next Y	-	ROA	-101.70%	Target Price	-	Perf Year	252.94%
Cash/sh	0.23	P/C	9.18	EPS next 5Y	-	ROE	-199.40%	52W Range	0.54 - 4.19	Perf YTD	174.83%
Dividend	-	P/FCF	-	EPS past 5Y	22.00%	ROI	-195.50%	52W High	-49.88%	Beta	0.06
Dividend %	-	Quick Ratio	16.30	Sales past 5Y	33.50%	Gross Margin	62.00%	52W Low	292.45%	ATR	0.35
Employees	11	Current Ratio	16.80	Sales Q/Q	0.00%	Oper. Margin	-	RSI (14)	43.86	Volatility	9.96% 10.48%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	97.50%	Profit Margin	-	Rel Volume	0.07	Prev Close	2.10
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	23.34M	Price	2.10
Recom	2.00	SMA20	-18.53%	SMA50	-0.43%	SMA200	62.65%	Volume	0	Change	0.00%

Sep-14-21 12:12PM	NanoVibronix Launches CBD-Based Product For Pain Management Benzinga -9.46%
08:30AM	NANOVIBRONIX EXTENDS LINE-UP OF PAIN MANAGEMENT PRODUCTS GlobeNewswire
Aug-17-21 02:32PM	NanoVibronix Announces Results of Annual Meeting of Stockholders Held Today Business Wire -12.76%
10:26AM	We're Hopeful That NanoVibronix (NASDAQ:NAOV) Will Use Its Cash Wisely Simply Wall St.
07:02AM	25 Stocks Moving in Tuesday's Pre-Market Session Benzinga
Aug-16-21 04:05PM	NanoVibronix Reports Second Quarter 2021 Financial Results; Provides Business Update GlobeNewswire +33.73%
12:13PM	Mid-Day Market Update: Crude Oil Down Over 2%; Travere Therapeutics Shares Jump Benzinga
10:22AM	Mid-Morning Market Update: Markets Open Lower; Empire State Manufacturing Index Dips In August Benzinga
08:30AM	NANOVIBRONIX ANNOUNCES PLAN TO EXPAND PRODUCT PORTFOLIO WITH INTRODUCTION OF PAINSHIELD RELIEF FOR OVER-THE-COUNTER (OTC) USE AND PLANS FOR FUTURE PRODUCT LAUNCH GlobeNewswire
Aug-11-21 08:30AM	NANOVIBRONIX RECEIVES REGISTRATION APPROVAL FOR PAINSHIELD FROM TGA AUSTRALIA GlobeNewswire
Aug-05-21 08:52AM	NanoVibronix Applies for CMS Reimbursement Code for UroShield® and PainShield Plus® Business Wire +20.10%
Jul-29-21 09:00AM	NanoVibronix Receives Registration Approval for UroShield From TGA Australia Business Wire +26.18%
Jul-26-21 10:47AM	NanoVibronix Ships First Order of PainShield Plus Business Wire -27.20%
04:44AM	Premarket Movers Monday: NanoVibronix, Alibaba, Lumen, Hasbro TheStreet.com
04:36AM	NanoVibronix Jumps on Positive UTI Medical Device Reception TheStreet.com
Jul-23-21 03:03PM	NanoVibronix stock triples in very active trading after upbeat report on UTI treatment MarketWatch +248.14%
Jul-22-21 08:15AM	NanoVibronix Announces Publication of Compelling Study Results for UroShield in The Journal of Medical & Surgical Urology GlobeNewswire -6.23%
Jun-03-21 08:30AM	NanoVibronix Provides Business Update GlobeNewswire +15.63%
Apr-27-21 11:17AM	NanoVibronix Adjourns Special Meeting of Stockholders GlobeNewswire
Apr-26-21 09:00AM	NanoVibronix Announces Expanded CMS Reimbursement Approval for PainShield GlobeNewswire +14.69%
Apr-19-21 09:50AM	NanoVibronix Announces Start of Real World Patient Study of UroShield Business Wire
Apr-14-21 12:57PM	NanoVibronix Adjourns Special Meeting of Stockholders GlobeNewswire +6.01%
Mar-31-21 06:50PM	NanoVibronix Adjourns Special Meeting of Stockholders Business Wire
Mar-02-21 08:30AM	NanoVibronix UroShield Joins PainShield on Federal Supply Schedule, Expanding Access to VA Market Business Wire
Feb-10-21 08:00AM	NanoVibronix Reports Schedule Published by NICE for Review of UroShield® Device Business Wire
Feb-03-21 08:00AM	NanoVibronix Regains Nasdaq Compliance Business Wire +7.03%
Jan-22-21 11:12AM	NAOV Stock: 7 Things to Know About Medical Device Company NanoVibronix InvestorPlace
Jan-19-21 08:00AM	NanoVibronix Issues Letter to Shareholders Business Wire
Dec-11-20 08:00AM	NanoVibronix Amends and Expands Distribution Agreement for Its PainShield® and PainShield Plus® Business Wire +6.28%
Dec-08-20 08:00AM	NanoVibronix Announces UroShield and PainShield Meet New Zealand Medicines and Medical Devices Safety Authority Regulatory Requirements Business Wire +9.00%
Dec-07-20 05:10PM	NanoVibronix Announces Closing of $6.0 Million Private Placement Priced At-the-Market Business Wire -8.26%
Dec-02-20 01:01PM	NanoVibronix Announces $6.0 Million Private Placement Business Wire +55.17%
07:54AM	Independent Study Finds Significant Benefits Provided by NanoVibronixs UroShield® Device Business Wire
Nov-16-20 06:12PM	NanoVibronix Reports Third Quarter 2020 Financial Results, Provides Business Update Business Wire
Oct-16-20 08:30AM	NanoVibronix Expands Offerings with Introduction of PainShield Plus® Business Wire
Oct-08-20 09:00AM	NanoVibronix Receives Positive Nasdaq Listing Determination Business Wire
Sep-29-20 08:49AM	NanoVibronix Files U.S. Patent Application for PainShield® for Delivery of Cannabinoids for Alleviation of Chronic and Acute Pain PR Newswire
Sep-22-20 08:36PM	NanoVibronix Increases Previously Announced Bought Deal to $1.8 Million PR Newswire +103.46%
06:11PM	NanoVibronix Announces $1.5 Million Bought Deal Offering PR Newswire
10:37AM	Why NanoVibronix's Stock Is Trading Higher Today Benzinga
08:00AM	NanoVibronix UroShield® Receives U.S. Food and Drug Administration Authorization for Entry into the U.S. PR Newswire
Aug-27-20 03:42PM	NanoVibronix Announces Closing of $3.4 Million Bought Deal Offering and Partial Exercise of Underwriter's Option to Purchase Additional Shares PR Newswire
Aug-24-20 10:58PM	NanoVibronix Increases Previously Announced Bought Deal to $3.25 Million PR Newswire -10.52%
05:23PM	NanoVibronix Announces $2.5 Million Bought Deal Offering PR Newswire
Aug-13-20 08:30AM	NanoVibronix Announces First Shipments of new UroShield Devices PR Newswire -13.51%
Jul-07-20 08:00AM	NanoVibronix Signs Two Year, Exclusive Distribution Agreement for PainShield PR Newswire +6.76%
Jun-16-20 08:00AM	NanoVibronix Fulfills its First Private Label Partnership with Medisana and Receives Award for PainShield PT 100 Quality PR Newswire +9.35%
Jun-01-20 08:00AM	NanoVibronix Expands License Agreement for UroShield® and PainShield with Existing Distributor to Include Canada and Turkey PR Newswire
Apr-02-20 11:06AM	SANUWAVE Health Announces Exclusive Licensing of NanoVibronix, Inc. Surface Acoustic Wave Ultrasound Technology GlobeNewswire
08:00AM	NanoVibronix Announces License Agreement for WoundShield Product PR Newswire
Apr-01-20 08:00AM	NanoVibronix Receives Reimbursement Approval from U.S. Centers for Medicare & Medicaid Services (CMS) for PainShield GlobeNewswire +8.84%

NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. Its principal products include UroShield, an ultrasound-based product to prevent bacterial colonization and biofilm in urinary catheters, enhance antibiotic efficacy, and decrease pain and discomfort associated with urinary catheter use; PainShield, a patch-based therapeutic ultrasound technology to treat pain, muscle spasm, and joint contractures; and WoundShield, a patch-based therapeutic ultrasound device, which facilitates tissue regeneration and wound healing. The company sells its products directly to patients, as well as through distributor agreements in the United States, Israel, Europe, India, and internationally. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
FASHEK CHRISTOPHER M	Director	Sep 29	Buy	0.79	10,000	7,887	10,000	Oct 09 04:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience